These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2093732)

  • 1. Potential for artifacts in monitoring for the detection of tumor associated antigens (TAG-72 and CEA) in serum from patients undergoing MAb-based diagnostic and therapeutic protocols.
    Ferroni P; Milenic DE; Roselli M; Carrasquillo JA; Raubitschek A; Schlom J; Colcher D
    Int J Biol Markers; 1990; 5(4):166-76. PubMed ID: 2093732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies.
    Ferroni P; Milenic DE; Roselli M; Carrasquillo JA; Raubitschek A; Schlom J; Colcher D
    Int J Rad Appl Instrum B; 1991; 18(4):383-7. PubMed ID: 1864726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
    Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple and sensitive assay for determination of human anti-idiotypic anti-B72.3 antibodies, which is not affected by the presence of tumour-associated glycoprotein 72.
    Reinsberg J; Schmolling J; Ackermann D
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):237-44. PubMed ID: 8721411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy.
    Primus FJ; Kelley EA; Hansen HJ; Goldenberg DM
    Clin Chem; 1988 Feb; 34(2):261-4. PubMed ID: 3277745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen.
    Hansen HJ; LaFontaine G; Newman ES; Schwartz MK; Malkin A; Mojzisik K; Martin EW; Goldenberg DM
    Clin Chem; 1989 Jan; 35(1):146-51. PubMed ID: 2642761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.
    Colcher D; Milenic DE; Ferroni P; Carrasquillo JA; Reynolds JC; Roselli M; Larson SM; Schlom J
    J Nucl Med; 1990 Jul; 31(7):1133-42. PubMed ID: 2362192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3.
    Ferroni P; Milenic DE; Schlom J; Colcher D
    J Clin Lab Anal; 1990; 4(6):465-73. PubMed ID: 2283566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assays.
    Oltrogge JB; Baum RP; Lema KN; Donnerstag B; Hör G
    Int J Biol Markers; 1997; 12(1):15-7. PubMed ID: 9176712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival.
    Miotti S; Negri DR; Valota O; Calabrese M; Bolhuis RL; Gratama JW; Colnaghi MI; Canevari S
    Int J Cancer; 1999 Feb; 84(1):62-8. PubMed ID: 9988234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of delayed-type hypersensitivity responses by monoclonal anti-idiotypic antibodies to tumor cells expressing carcinoembryonic antigen and tumor-associated glycoprotein-72.
    Irvine K; Schlom J
    Cancer Immunol Immunother; 1993 May; 36(5):281-92. PubMed ID: 7682893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma.
    Baum RP; Niesen A; Hertel A; Nancy A; Hess H; Donnerstag B; Sykes TR; Sykes CJ; Suresh MR; Noujaim AA
    Cancer; 1994 Feb; 73(3 Suppl):1121-5. PubMed ID: 8306256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-murine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay.
    Price T; Beatty BG; Beatty JD; McNally AJ
    Clin Chem; 1991 Jan; 37(1):51-7. PubMed ID: 1988209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein-72 (TAG-72) in human colon adenocarcinomas.
    Simpson JF; Primus FJ; Schlom J
    Int J Biol Markers; 1991; 6(2):83-90. PubMed ID: 1716293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified method for determining carcinoembryonic antigen in the presence of human anti-murine antibodies.
    Morrissey NE; Quadri SF; Kinders R; Brigham C; Rose S; Blend MJ
    Clin Chem; 1993 Mar; 39(3):522-9. PubMed ID: 8448870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
    Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
    Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artifactual CEA elevation due to human anti-mouse antibodies.
    Morton BA; O'Connor-Tressel M; Beatty BG; Shively JE; Beatty JD
    Arch Surg; 1988 Oct; 123(10):1242-6. PubMed ID: 3178471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
    Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
    Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma.
    Juweid ME; Hajjar G; Swayne LC; Sharkey RM; Suleiman S; Herskovic T; Pereira M; Rubin AD; Goldenberg DM
    Cancer; 1999 Apr; 85(8):1828-42. PubMed ID: 10223579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.